t (14;16) by FISH (Research purpose only) at Chughtai Lab

Introduction to t (14;16) by FISH (Research purpose only) at Chughtai Lab

The t(14;16) translocation by Fluorescence In Situ Hybridization (FISH) is a highly specialized molecular cytogenetic assay designed to detect the specific chromosomal translocation between chromosome 14 and chromosome 16. This translocation, designated as t(14;16)(q32;q23), involves the immunoglobulin heavy chain (IGH) locus on chromosome 14q32 and the MAF oncogene on chromosome 16q23. In clinical and translational oncology, this genetic aberration is primarily associated with plasma cell dyscrasias, most notably multiple myeloma. Chughtai Lab, a premier diagnostic network in Pakistan, offers this advanced molecular investigation under the “Research Purpose Only” (RUO) designation to support academic research, clinical trials, and investigational cytogenetic profiling across its extensive laboratory network.

Fluorescence In Situ Hybridization (FISH) utilizes fluorescently labeled DNA probes that specifically hybridize to complementary genomic sequences on chromosomes 14 and 16. By utilizing high-resolution fluorescence microscopy, cytogeneticists can visualize and enumerate the physical proximity of these gene loci. In a normal cell, the IGH and MAF genes remain distinct and separated. However, in cells harboring the t(14;16) translocation, the fusion of these loci produces a distinct overlapping fluorescent signal. Understanding this translocation is of paramount importance because the juxtaposition of the powerful IGH enhancer elements next to the MAF gene leads to the pathological overexpression of the MAF transcription factor, driving cellular proliferation, anti-apoptotic pathways, and drug resistance in malignant plasma cells.

As a “Research Purpose Only” assay, this test is critical for researchers, oncologists, and clinical trial coordinators who are mapping the genomic landscape of hematological malignancies in Pakistan. It provides invaluable data on clonal evolution, prognostic stratification, and the prevalence of high-risk cytogenetic markers within the local population. Chughtai Lab performs this assay in its state-of-the-art molecular pathology division, utilizing advanced hybridization equipment and high-precision imaging systems to deliver reproducible and scientifically robust data.

Clinical Procedure: What to Expect

Patient Preparation

Because the t(14;16) by FISH assay is typically performed on bone marrow aspirate samples (and occasionally peripheral blood), patient preparation is highly dependent on the specimen collection method prescribed by the referring physician. Patients should observe the following guidelines:

• Consultation: Discuss the procedure with your hematologist or oncologist. Ensure that a formal consent form for genetic/research testing is signed, as this is an investigational and research-use assay.
• Medication Review: Inform your physician of all medications you are currently taking, especially anticoagulants (blood thinners) such as aspirin, warfarin, clopidogrel, or direct oral anticoagulants, as these can increase the risk of bleeding during a bone marrow aspiration.
• Fasting Requirements: Routine fasting is generally not required for a standard peripheral blood draw. However, if a bone marrow aspiration is scheduled under conscious sedation or local anesthesia, your physician may instruct you to fast for 6 hours prior to the procedure.
• Hygiene: If undergoing a bone marrow biopsy/aspiration, bathe or shower prior to the appointment, paying close attention to the lower back and hip area where the sample is typically collected.
• Post-Procedure Support: Arrange for a family member or friend to drive you home if you are undergoing a bone marrow aspiration with sedation.

During the Procedure

The specimen collection and laboratory processing of the t(14;16) by FISH test involve several precise steps to ensure sample integrity and analytical accuracy:

• Specimen Collection (Bone Marrow): A qualified hematologist or trained clinical specialist performs the bone marrow aspiration. The patient is positioned comfortably, usually lying on their side or stomach. The skin over the posterior superior iliac spine is cleaned with an antiseptic solution and numbed with a local anesthetic. A specialized needle is inserted into the bone, and a small volume of liquid bone marrow is aspirated into a syringe containing an anticoagulant (usually sodium heparin).
• Specimen Collection (Peripheral Blood): In cases where circulating plasma cells are high or bone marrow is inaccessible, peripheral blood may be collected via standard venipuncture into a green-top (sodium heparin) tube.
• Transport and Accessioning: The specimen is immediately labeled and transported to the Chughtai Lab molecular genetics department under temperature-controlled conditions to maintain cell viability.
• Laboratory Processing: In the laboratory, the nucleated cells are harvested, cultured if necessary, and fixed onto glass slides. The slides undergo denaturation to separate the double-stranded DNA.
• Probe Hybridization: Specially designed fluorescent probes for the IGH and MAF loci are applied to the slide. The slide is incubated overnight to allow the probes to hybridize to their target genomic sequences.
• Washing and Counterstaining: Unbound probes are washed away, and the nuclei are counterstained with a fluorescent dye (DAPI) to visualize the cellular structure.
• Analysis: A cytogeneticist analyzes the slides using a high-resolution fluorescence microscope equipped with specialized filters. At least 100 to 200 interphase nuclei are typically enumerated to determine the percentage of cells displaying the fusion signal.

When is a t (14;16) by FISH Test Performed?

Multiple Myeloma Prognostication

The t(14;16) translocation is classified as a high-risk cytogenetic abnormality in multiple myeloma. Clinicians request this cytogenetic profiling to categorize patients into specific risk groups. Patients harboring this translocation often experience a more aggressive disease course and may require intensive therapeutic strategies. Identifying this marker helps researchers and clinicians understand the underlying molecular drivers of the disease.

Investigational Oncology Research

As an RUO assay, this test is frequently performed within academic medical centers and research institutions in Pakistan. Researchers utilize the t(14;16) FISH assay to study the molecular epidemiology of plasma cell disorders, evaluate the correlation between specific genetic markers and patient outcomes, and contribute to global oncological databases regarding South Asian patient cohorts.

Monitoring Minimal Residual Disease (MRD) and Clonal Evolution

During clinical trials or investigational therapeutic protocols, researchers perform serial FISH testing to monitor the persistence of the t(14;16) clone. This assists in evaluating the efficacy of novel therapeutic agents targeting specific molecular pathways and helps detect the emergence of resistant clonal populations over time.

Stratification in Clinical Trials

Pharmaceutical companies and clinical trial coordinators utilize this assay to stratify patients entering clinical trials for novel myeloma therapies. Because certain modern drugs, such as specific proteasome inhibitors or monoclonal antibodies, may show differential efficacy in patients with high-risk cytogenetics, verifying the presence of t(14;16) is crucial for trial eligibility and subgroup analysis.

Cytogenetic Profiling of Plasma Cell Dyscrasias

Physicians investigating atypical plasma cell disorders, such as primary plasma cell leukemia or advanced monoclonal gammopathy of undetermined significance (MGUS), may request this test to perform comprehensive genomic profiling. This helps in mapping the complete cytogenetic landscape of the patient’s disease, contributing to a deeper understanding of the biological transition from premalignant states to active malignancy.

What Does a t (14;16) by FISH Test Detect?

The t(14;16) by FISH assay is designed to detect and quantify specific cytogenetic and molecular parameters within the submitted sample. The assay evaluates and detects:

• The presence of the t(14;16)(q32;q23) chromosomal translocation.
• The fusion of the Immunoglobulin Heavy Chain (IGH) gene locus on chromosome 14 with the MAF gene locus on chromosome 16.
• The percentage of interphase nuclei displaying abnormal fusion signals.
• The presence of atypical signal patterns, such as extra copies of the fusion gene.
• The deletion of the non-rearranged IGH or MAF alleles in malignant cells.
• Aneuploidy of chromosome 14, including monosomy or trisomy.
• Aneuploidy of chromosome 16, indicating numerical chromosomal abnormalities.
• The clonal size of the translocation-positive cell population within the sample.
• The presence of structural variations near the 14q32 breakpoint region.
• The presence of structural variations near the 16q23 breakpoint region.
• The quality and intensity of the fluorescent signals, ensuring assay validity.
• The hybridization efficiency of the specific locus-specific probes.
• The background noise and autofluorescence levels within the specimen.
• The total number of viable nucleated cells available for cytogenetic analysis.
• The presence of normal diploid cell populations acting as internal controls.
• The co-existence of numerical abnormalities associated with the target chromosomes.
• The presence of atypical signal patterns resulting from complex multi-partner translocations.
• The genomic stability of the target loci across the analyzed cell population.
• The technical suitability of the bone marrow or blood specimen for cytogenetic evaluation.
• The presence of subclonal populations harboring the t(14;16) translocation.

Turnaround Time and Report Access at Chughtai Lab

The t(14;16) by FISH (Research purpose only) assay is a highly complex molecular procedure requiring meticulous laboratory preparation, hybridization, and expert microscopic analysis. Consequently, the turnaround time for this specialized test is typically longer than routine hematology or biochemistry investigations. Generally, results are finalized within 7 to 10 working days from the receipt of the specimen at the central molecular reference laboratory of Chughtai Lab.

Chughtai Lab provides convenient and secure access to diagnostic reports. Once the cytogenetic analysis is completed and verified by a consultant pathologist, the report is uploaded directly to the Chughtai Lab online portal and mobile application. Patients and researchers can download the PDF report using their unique patient ID and password. Additionally, an SMS notification is sent to the registered mobile number as soon as the report is ready, ensuring seamless communication and timely access to critical research data.

t (14;16) by FISH Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
IGH/MAF Fusion Signals	Negative (Two separate orange and two separate green signals)	Positive (Presence of yellow fusion signals or overlapping orange/green signals)
Nuclei Analyzed	Minimum of 100-200 intact, non-overlapping nuclei evaluated	Inadequate sample quality resulting in fewer than 100 evaluable nuclei
IGH Gene Status (14q32)	Two intact, non-rearranged IGH alleles	Rearranged IGH locus with translocation to chromosome 16 or other partner
MAF Gene Status (16q23)	Two intact, non-rearranged MAF alleles	Rearranged MAF locus with translocation to chromosome 14 or other partner
Signal Pattern	Standard 2O2G (2 Orange, 2 Green) pattern	Atypical patterns (e.g., 1O1G2F, indicating loss of alleles or complex rearrangements)
Chromosome 14 Ploidy	Diploid (Two copies of chromosome 14)	Monosomy 14, trisomy 14, or other numerical abnormalities
Chromosome 16 Ploidy	Diploid (Two copies of chromosome 16)	Monosomy 16, trisomy 16, or other numerical abnormalities
Hybridization Efficiency	High efficiency (>95% of nuclei showing clear, bright signals)	Low hybridization efficiency requiring assay repeat or sample rejection

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for t (14;16) by FISH?

• Experienced Healthcare Professionals: Chughtai Lab employs highly qualified pathologists, cytogeneticists, and laboratory technologists specializing in molecular diagnostics.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Chughtai Lab adheres to stringent international quality control standards across all its testing panels.
• Professional Reporting: Reports are detailed, structured, and reviewed by consultant pathologists to ensure clinical and scientific accuracy.
• Modern Diagnostic Approach: The molecular genetics department utilizes advanced fluorescence microscopes and high-precision hybridization systems.
• Comfortable Environment: Specimen collection centers are designed to provide a clean, professional, and welcoming atmosphere for patients.
• Convenient Location: With an extensive network of collection centers across Pakistan, accessing specialized testing is convenient.
• Commitment to Accurate Diagnosis: Chughtai Lab is dedicated to providing reliable, evidence-based diagnostic support for clinical and research purposes.